Stratec - Public Comps and Valuation Multiples

Stratec Overview

About Stratec

Stratec SE designs and manufactures automated analyzer systems for laboratory data management and solutions for molecular diagnostic sample preparation and stabilization. Its business segments are Instrumentation, Diatron and Smart Consumables. Its Instrumentation segment is engaged in designing and manufacturing automated analyzer systems for clinical diagnostics and biotechnology customers. The Diatron segment comprises the business with systems, system components, consumables, and tests in the low throughput hematology and clinical chemistry segment. Its Smart Consumables segment is engaged in developing and selling scientific materials, such as nucleic acid purification. The company generates maximum revenue from the Instrumentation segment.

Founded

1979

HQ

Employees

1.5K+

Website

stratec.com

Sectors

Medical Devices
DeepTech
HealthTech

Financials

LTM Revenue $282M

LTM EBITDA $51.7M

EV

$407M

Valuation Multiples

Multiples.vc

Valuation Multiples for 10K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Browse Valuation Multiples

Stratec Financials

Stratec has a last 12-month revenue of $282M and a last 12-month EBITDA of $51.7M.

In the most recent fiscal year, Stratec achieved revenue of $281M and an EBITDA of $42.9M.

Stratec expects next 12-month revenue of XXX and NTM EBITDA of XXX

See Stratec valuation multiples based on analyst estimates

Stratec P&L

	FY 2023	FY 2024	FY 2025	LTM	NTM
Revenue	$281M	$277M	XXX	XXX	XXX
Gross Profit	$94.2M	$85.4M	XXX	XXX	XXX
Gross Margin	33%	31%	XXX	XXX	XXX
EBITDA	$42.9M	$49.4M	XXX	XXX	XXX
EBITDA Margin	15%	18%	XXX	XXX	XXX
Net Profit	$42.9M	$31.4M	XXX	XXX	XXX
Net Margin	15%	11%	XXX	XXX	XXX
Net Debt	$30.8M	$54.7M	XXX	XXX	XXX

Financial data powered by Morningstar, Inc.

Stratec Stock Performance

As of April 15, 2025, Stratec's stock price is EUR 22 (or $24).

Stratec has current market cap of EUR 272M (or $292M), and EV of EUR 379M (or $407M).

See Stratec trading valuation data

Stratec Stock Data

EV	Market Cap	Price 1D	Price 1M	Price 3M	Price 12M	EPS
$407M	$292M	XXX	XXX	XXX	XXX	$1.67

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Stratec Valuation Multiples

As of April 15, 2025, Stratec has market cap of $292M and EV of $407M.

Stratec's trades at 1.4x LTM EV/Revenue multiple, and 7.9x LTM EBITDA.

Analysts estimate Stratec's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

See valuation multiples for Stratec and 10K+ public comps

Stratec Financial Valuation Multiples

	FY 2024	FY 2025E	FY 2026E	FY 2027E
EV	$407M	XXX	XXX	XXX
EV/Revenue	1.5x	XXX	XXX	XXX
EV/EBITDA	8.2x	XXX	XXX	XXX
P/E	18.4x	XXX	XXX	XXX
P/E/Growth	0.6x	XXX	XXX	XXX
EV/FCF	9.6x	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Stratec Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Stratec Valuation Multiples

Stratec's NTM/LTM revenue growth is 7%

Stratec's revenue per employee for the last fiscal year averaged $0.2M, while opex per employee averaged $28K for the same period.

Over next 12 months, Stratec's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .

Analysts estimate Stratec's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

See operational valuation multiples for Stratec and other 10K+ public comps

Stratec Operational Valuation Multiples

	FY 2024	NTM	FY 2025E	FY 2026E	FY 2027E
Revenue Growth	-2%	XXX	XXX	XXX	XXX
EBITDA Margin	18%	XXX	XXX	XXX	XXX
EBITDA Growth	15%	XXX	XXX	XXX	XXX
Rule of 40 (SaaS-only)	25%	XXX	XXX	XXX	XXX
Revenue per Employee	$0.2M	XXX	XXX	XXX	XXX
Opex per Employee	$28K	XXX	XXX	XXX	XXX
S&M Expenses to Revenue	5%	XXX	XXX	XXX	XXX
G&A Expenses to Revenue	7%	XXX	XXX	XXX	XXX
R&D Expenses to Revenue	3%	XXX	XXX	XXX	XXX
Opex to Revenue	15%	XXX	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics

Pharma Analytics

Private Equity

ERP Software

Developer Tools

Consumer SaaS

Streaming Platforms

Explore Valuation Multiples by Industry